Baby&MOM Partners with NANOTEC (NSTDA) to Elevate Thai Herbs into Women's Health and Pre-conception Innovations for Global Market

Baby&MOM (Thailand) Co., Ltd. is reinforcing its brand as the "Science of Motherhood" through a partnership with the National Nanotechnology Center (NANOTEC) and the National Science and Technology Development Agency (NSTDA). This collaboration aims to leverage knowledge, research, and technology to transform Thai herbs into innovative products for women's health and pre-conception readiness, thereby adding value and enhancing the competitiveness of Thai products in the global market. The partnership was highlighted at a special seminar titled "PhytoEX: Driving the Future of Longevity Nutraceuticals – From Thai Roots to the World" during Vitafoods Asia 2026, an international platform for health supplements and innovations. Mr. Rueangsak Loychusak, Chairman of Baby&MOM (Thailand), and Khru Koy-Natcha Loychusak, Executive Director of Baby&MOM (Thailand) and founder of the scientific pregnancy preparation knowledge platform Baby&MOM, shared insights on translating consumer needs into research objectives and developing them into scientifically supported products. Mr. Rueangsak stated that for over nine years, Baby&MOM has been dedicated to building knowledge for pre-conception readiness and developing products that meet consumer needs, with verifiable data, research, and test results as fundamental pillars. "The collaboration with NANOTEC NSTDA is not limited to using extracts in products but encompasses defining research objectives, selecting key components and appropriate technologies, as well as conducting tests to obtain credible scientific data," he explained. "This aligns with Baby&MOM's goal of elevating the standards for women's health and pre-conception products to foster growth both domestically and internationally." Khru Koy-Natcha added that reproductive readiness is not solely dependent on age but also on overall health, lifestyle, and the body's internal environment. Baby&MOM utilizes its experience working closely with women planning for pregnancy to develop research questions with scientists, creating products that more precisely meet consumer demands. "Today's consumers prioritize the origin of active ingredients, scientific data, and test results. Therefore, we collaborate with researchers from raw material selection and technology application to testing, to develop high-quality, trustworthy products that truly address women's health needs," she said. Under this partnership, Baby&MOM is incorporating innovations from the PhytoEX program and the SulforaEX active ingredient into new product development. This initiative supports the growth of the nutraceuticals market and the trend towards preventative health management and long-term wellness, or longevity. SulforaEX is an innovation developed to meet the demands of the modern health market, with potential for high-value health product development and necessary testing to ensure quality, safety, and consumer confidence. Mr. Rueangsak further commented that this collaboration embodies Baby&MOM's "Where Science Meets Motherhood" concept, using science as the foundation for education and product development to care for women throughout their motherhood journey. By leveraging Thai resources and wisdom with research and technology, they aim to create globally competitive innovations. "We believe Thai herbs have greater potential than just being raw materials. When enhanced with science, technology, and market understanding, they can be developed into high-value health innovations capable of competing globally. The collaboration with NANOTEC NSTDA is a crucial mechanism for elevating Baby&MOM's products and jointly pushing Thai health innovations into the global market," he concluded. The collaboration between Baby&MOM and NANOTEC NSTDA effectively links research capabilities with consumer understanding and market demands, transforming Thai herbs into value-added nutraceutical products. This effort supports Thailand's transition from a raw material production base to a developer of health innovations with its own knowledge and technology, capable of sustainable competition in the global health market. Information Source: INN News